In the latest trading session, Moderna (MRNA) closed at $30.41, marking a -2.38% move from the previous day. This move lagged ...
The day after Christmas is supposed to be one of the better days of the year. It’s not looking like that right now. After trading higher to start the day, the S&P 500 has dipped 0.04%, while the Dow ...
This stock is a great choice for cautious and aggressive investors.
Investor's Business Daily on MSN
Moderna stock sees healthy relative strength rating
Moderna earns the No. 356 rank among its peers in the Medical-Biomed/Biotech industry group. Exact Sciences EXAS, Genmab ADR GMAB and Krystal Biotech KRYS are among the top 5 highly rated stocks ...
Follow live coverage of the stock market's moves today. The Dow Jones Industrial Average, S&P 500, and Nasdaq are all flat in morning trading hours.
The appointment of a fervent vaccine opponent — Robert F. Kennedy Jr. — as secretary of the Department of Health and Human ...
Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...
With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...
The Vaccine Adverse Event Reporting System (VAERS) was established to protect public health. Now it's being used against it.
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback